In High phosphate levels in blood Our body needs phosphate for various life functions such as strengthening of bones and teeth, production of energy, and forming outer layers of cells in our body called the cell membrane. But too much phosphate in our blood can cause serious complications such as heart attack, stroke as well as kidney damage. Sevtreat 400mg Tablet helps to lower the phosphate levels in our blood and prevents these complications particularly in patients who are on dialysis and are unable to get rid of excess phosphate levels through kidneys. Take Sevtreat 400mg Tablet as prescribed by the doctor to get the most of this medicine.
It is not known whether it is safe to consume alcohol with Sevtreat 400mg Tablet. Please consult your doctor.
Sevtreat 400mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Sevtreat 400mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
It is not known whether Sevtreat 400mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Sevtreat 400mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Sevtreat 400mg Tablet is recommended. However, regular monitoring of calcium levels is advisable in these patients.
Sevtreat 400mg Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Sevtreat 400mg Tablet may not be needed in these patients. Please consult your doctor.
If you miss a dose of Sevtreat 400mg Tablet, skip it and continue with your normal schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Myren Life Science India Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Emcure Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: La Renon Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Neuten Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Rencord Life Sciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intas Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Medgenix Pharma India Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Mediart Lifesciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Elera Pharma || ₹14.5/tablet (25% cheaper)